Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2024-05-24 00:00:00 ET · period of report 2024-05-22 · accession 0000875320-24-000158 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-24 | 2024-05-22 | VRTX | SACHS BRUCE I | Dir | M - OptEx | $93.51 | +7,073 | 47.1K | +18% | +$661.4K |
| D | 2024-05-24 | 2024-05-22 | VRTX | SACHS BRUCE I | Dir | S - Sale+OE | $448.00 | -7,073 | 40.0K | -15% | -$3.17M |
| D | 2024-05-24 | 2024-05-22 | VRTX | SACHS BRUCE I | Dir | M - OptEx | $0.00 | -7,073 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-22 | M | A | 7,073 | $93.51 | 47,073 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-22 | S | D | 7,073 | $448.00 | 40,000 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-05-22 | M | D | 7,073 | $0.00 | 0 | D | $93.51 · — to 2026-05-31 | 7,073 Common Stock | (F2) Fully vested. |